
Tandem Diabetes Care TNDM
$ 16.62
-5.62%
Quarterly report 2026-Q1
added 05-07-2026
Tandem Diabetes Care P/S Ratio 2011-2026 | TNDM
Annual P/S Ratio Tandem Diabetes Care
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.35 | 7.9 | 1.96 | 3.22 | 10.6 | 11.3 | 12 | 11.3 | 0.145 | 0.835 | 3.58 | 5.75 | 2.6 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12 | 0.145 | 5.81 |
P/S Ratio of other stocks in the Medical devices industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
0.939 | - | -10.19 % | $ 1.99 M | ||
|
EDAP TMS S.A.
EDAP
|
0.936 | - | - | $ 162 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
5.44 | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
0.339 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
10.3 | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
0.456 | - | - | $ 10.2 M | ||
|
Lianluo Smart Limited
LLIT
|
409 | - | 24.59 % | $ 44.8 M | ||
|
Allied Healthcare Products
AHPI
|
0.894 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
22 | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
8.55 | $ 13.72 | 0.96 % | $ 388 M | ||
|
Apollo Endosurgery
APEN
|
5.24 | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
2.7 | $ 8.23 | -0.36 % | $ 1.24 B | ||
|
Aziyo Biologics
AZYO
|
1.09 | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
183 | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
0.0039 | - | -13.19 % | $ 166 K | ||
|
IRIDEX Corporation
IRIX
|
0.315 | $ 1.15 | 2.67 % | $ 19.5 M | ||
|
Conformis
CFMS
|
0.204 | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
2.55 | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
670 | $ 1.49 | 0.34 % | $ 32.9 M | ||
|
CryoLife, Inc.
CRY
|
3.58 | - | -4.14 % | $ 702 M | ||
|
LivaNova PLC
LIVN
|
2.74 | $ 78.94 | 2.29 % | $ 4.31 B | ||
|
CHF Solutions, Inc.
CHFS
|
0.19 | - | 1.15 % | $ 34.5 M | ||
|
Cytosorbents Corporation
CTSO
|
0.94 | $ 0.41 | -2.6 % | $ 25.5 M | ||
|
Pulmonx Corporation
LUNG
|
0.805 | $ 1.51 | -1.63 % | $ 61.4 M | ||
|
OrthoPediatrics Corp.
KIDS
|
1.85 | $ 18.53 | 0.22 % | $ 435 M | ||
|
Delcath Systems
DCTH
|
3.83 | $ 11.54 | -1.28 % | $ 413 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
1.88 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
8.25 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
2.96 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
266 | - | - | $ 111 M | ||
|
LENSAR
LNSR
|
1.22 | $ 5.66 | -0.53 % | $ 67.7 M | ||
|
Orthofix Medical
OFIX
|
0.598 | $ 9.97 | 0.96 % | $ 395 M | ||
|
Dynatronics Corporation
DYNT
|
0.0712 | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
2.73 | $ 36.96 | 1.57 % | $ 312 M | ||
|
MiMedx Group
MDXG
|
1.86 | $ 3.74 | 0.81 % | $ 553 M | ||
|
Butterfly Network
BFLY
|
9.7 | $ 5.47 | 6.53 % | $ 1.35 B | ||
|
Intersect ENT, Inc.
XENT
|
9.12 | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
44.4 K | - | -0.97 % | $ 54.4 M | ||
|
Myomo
MYO
|
0.828 | $ 1.49 | 12.88 % | $ 62.4 M | ||
|
GBS
GBS
|
0.812 | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
4.24 | $ 81.52 | -1.22 % | $ 11 B | ||
|
Insulet Corporation
PODD
|
6.7 | $ 156.0 | -2.26 % | $ 11 B | ||
|
Profound Medical Corp.
PROF
|
10.3 | $ 6.9 | 1.17 % | $ 209 M | ||
|
CONMED Corporation
CNMD
|
0.959 | $ 36.47 | -1.06 % | $ 1.13 B | ||
|
Inspire Medical Systems
INSP
|
1.93 | $ 42.93 | 1.78 % | $ 1.26 B | ||
|
Integer Holdings Corporation
ITGR
|
1.61 | $ 93.16 | -0.86 % | $ 3.24 B | ||
|
Invacare Corporation
IVC
|
0.133 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
8.05 | $ 86.56 | -1.1 % | $ 50.6 B | ||
|
Sintx Technologies
SINT
|
6.78 | $ 2.11 | -0.24 % | $ 5.85 M |